Sorted By:

Relevance


World Cancer Day: Revolutionizing Treatment for Patients is “Not Beyond Us”

PhRMA  |  Blog Post

If you’re looking to get involved in World Cancer Day, share this post or the videos and be sure to use the hashtags #WorldCancerDay and #NotBeyondUs to help spread the world about how innovative cancer medicines are enabling people to take back their lives.
http://catalyst.phrma.org/world-cancer-day-revolutionizing-treatment-for-patients-is-not-beyond-us

Medicare Monday: Happy Memorial Day!

PhRMA  |  Blog Post

Get instant updates on issues you care about - here.
http://catalyst.phrma.org/medicare-monday-happy-memorial-day

Patients showcase longer, healthier lives in new “From Hope to Cures” ads

PhRMA  |  Blog Post

Learn more here about the campaign and how America’s biopharmaceutical companies are driving innovation, collaborating and helping to translate new findings into hope for America’s patients.
http://catalyst.phrma.org/new-patients-showcase-longer-healthier-lives-in-recent-from-hope-to-cures-ads

State Leaders See Bioscience as Jobs Engine

PhRMA  |  Blog Post

Indiana labor, business and policy leaders get it.
http://catalyst.phrma.org/state-leaders-see-bioscience-as-jobs-engine

How Does Health Insurance Cover Your Medicines?

PhRMA  |  Video

This video explains some key points that help navigate coverage, including formularies and medicine tiers.
http://www.phrma.org/video/how-does-health-insurance-cover-your-medicines

New Avalere study: Health plan formularies continue to suggest bias against individuals with certain health conditions

PhRMA  |  Blog Post

Learn more about this and other policy solutions to engage and empower consumers here.
http://catalyst.phrma.org/new-avalere-study-health-plan-formularies-continue-to-suggest-bias-against-individuals-with-certain-health-conditions

340B Spotlight: Trends in shifting site of care

PhRMA  |  Blog Post

Learn more about policy solutions to address market distortions here
http://catalyst.phrma.org/340b-spotlight-trends-in-shifting-site-of-care

Medicare Monday: New research reveals Part D coverage is more robust than VA coverage for new, innovative medicines

PhRMA  |  Blog Post

Learn more about Medicare Part D here.
http://catalyst.phrma.org/medicare-monday-new-research-reveals-part-d-coverage-is-more-robust-than-va-coverage

Burden on patients: Access to medicines in health insurance exchange plans

PhRMA  |  Blog Post

Multiple sclerosis (MS): While coverage is improving, more than one-third (36 percent) of marketplace plans still place all innovator brand MS medicines on the specialty tier.
http://catalyst.phrma.org/burden-on-patients-access-to-medicines-in-health-insurance-exchange-plans

PhRMA: Propuesta de Clinton Volvería Atrás el Reloj en la Innovación Médica

PhRMA  |  Press Release

• Arriesga la seguridad del paciente al permitir la importación de medicamentos desde el extranjero sin evidencia de ahorros.
http://www.phrma.org/press-release/phrma-propuesta-de-clinton-volver-a-atr-s-el-reloj-en-la-innovaci-n-m-dica

World Asthma Day: New Hope for Millions with Asthma

PhRMA  |  Blog Post

PhRMA’s From Hope to Cures has resources dedicated to increasing awareness about asthma as well as information about new treatments targeting this chronic condition.
http://catalyst.phrma.org/world-asthma-day-new-hope-for-millions-with-asthma

ICYMI: New Commonwealth Fund Study Shows Health Insurance Does Not Always Translate to Affordable Care

PhRMA  |  Blog Post

Get ABC and other updates here.
http://catalyst.phrma.org/new-commonwealth-fund-study-shows-health-insurance-does-not-always-translate-to-affordable-care

New Medicines in Development for Women

PhRMA  |  Video

America’s pharmaceutical research and biotechnology companies continue making exciting progress in the search for new cures and treatments for diseases of special concern to women.
http://www.phrma.org/video/new-medicines-in-development-for-women

YMCA Healthy Kids Day: Promoting Childhood Wellness

PhRMA  |  Blog Post

They are crucial to protecting our children so that they can have fun at events like the YMCA’s Healthy Kids Day.
http://catalyst.phrma.org/ymca-healthy-kids-day-promoting-childhood-wellness

New prostate cancer treatment will get its first test in Omaha

From Hope To Cures  |  From Our Network

The society estimates that 220,800 new cases were found in 2015 and that 27,540 men died of the disease.
http://www.fromhopetocures.org/new-prostate-cancer-treatment-will-get-its-first-test-in-omaha

ICYMI: More than 60 PhRMA company scientists visit Capitol Hill

PhRMA  |  Blog Post

To learn more about the men and women of America’s biopharmaceutical research companies, visit: http://www.fromhopetocures.org/science Lilly scientists met with @RepToddYoung today to chat about their work and the importance of health .com/hashtag/innovation?
http://catalyst.phrma.org/icymi-more-than-60-phrma-company-scientists-visit-capitol-hill

New report highlights need to speed patent examination

PhRMA  |  Blog Post

The United Kingdom’s Intellectual Property Office estimated that combined losses from each year of backlog in the U.S.
http://catalyst.phrma.org/new-report-highlights-need-to-speed-patent-examination

Cancer treatments got gentler, yet kids’ survival improved

From Hope To Cures  |  From Our Network

"We have actually reduced treatment, reduced therapy," and yet improved survival, he said.
http://www.fromhopetocures.org/cancer-treatments-got-gentler-yet-kids-survival-improved

Medicines in Development for Arthritis 2014 Report

PhRMA  |  Report

New medicines today in the research and development pipeline offer hope of reducing the human and economic costs of the many musculoskeletal disorders affecting Americans.
http://www.phrma.org/report/medicines-in-development-for-arthritis-2014-report

New Avalere Study: Health Plan Bias

PhRMA  |  Fact Sheet

Despite warnings from the Centers for Medicare & Medicaid Services (CMS) that requiring high cost sharing for all or most medications to treat a condition may be discriminatory, new data from Avalere show some health plans are continuing to engage in this practice.
http://www.phrma.org/fact-sheet/new-avalere-study-health-plan-bias

New Chart Pack: Biopharmaceuticals in Government Programs

PhRMA  |  Blog Post

  Medicines in Medicare Part D Beneficiaries Save Through Plan Competition and Manufacturer Negotiations   Medicines in Medicare Part B Program Spending on Prescription Medicines Accounted for About 8% of Part B Spending in 2012   Medicines in Medicaid On Average, About 60% of the Initial Cost of Brand Medicines is Returned to States Through Rebates   Medicines in Veterans Affairs VA Formulary Covers Fewer Drugs Than Part D Medicines in 340B Without Significant Reforms 340B Will Continue to Grow as Uninsured Rate Declines Check out PhRMA’s other chart pack resources here and check back with our Medicare Monday series and 340B Spotlight as we take a deeper look at some of these charts in the coming weeks.
http://catalyst.phrma.org/new-chart-pack-biopharmaceuticals-in-government-programs

Robert Suter, D.O.

PhRMA  |  Biography

Suter also holds appointments as a Professor at the Medical College of Georgia, Des Moines University and the Uniformed Services University of the Health Sciences, where he serves as a Colonel in the U.S.
http://www.phrma.org/biography/robert-suter-d-o

Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts

PhRMA  |  Press Release

Scangos was appointed CEO of Biogen Idec in June 2010.
http://www.phrma.org/press-release/pfizer-s-ian-read-becomes-phrma-board-chairman-ken-frazier-george-scangos-assume-new-posts

New First-of-Its-Kind Study Shows Growing Share of Medicine List Prices Going to Rebates and Supply Chain

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
http://www.phrma.org/press-release/new-first-of-its-kind-study-shows-growing-share-of-medicine-list-prices-going-to-rebates-and-supply-chain

In biopharmaceutical research, if at first you don’t succeed, try again

PhRMA  |  Blog Post

With over 7,000 new medicines currently in development, patients today have more hope for a better quality of life.
http://catalyst.phrma.org/in-biopharmaceutical-research-if-at-first-you-dont-succeed-try-again

You have reviewed the first 150 results out of 1971. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next